Facing Eating Disorder Fears for Anorexia Nervosa — FED-F  

Anorexia Nervosa Clinical Trial

Official title: Facing Eating Disorder Fears for Anorexia Nervosa: A Virtual Relapse Prevention Program Targeted at Approach and Avoidance Behaviors

Status Recruiting

Clinical Trial Summary

FED-F is a modular treatment that enhances exposure therapy with psychoeducation and cognitive skills teaching how to face fears of (a) food, (b) weight gain, (c) interoception/body, and (d) social situations. The study goals are to (1) refine and test the acceptability and feasibility of FED-F treatment (Phase I), (2) test if this treatment outperforms treatment as usual (TAU) delivered post-acute treatment as adjunctive to stepdown specialty care (Phase II), and (3) to examine if treatment targets the hypothesized mechanism of action: approach behaviors (Phase II). These goals will lead to a highly deployable and accessible virtual treatment targeted at core AN mechanisms that predict relapse. Specific aims are to (1) refine FED-F into a fully virtual format with input from patients and stakeholders and collect preliminary data (N=10) on its feasibility and acceptability (Phase I), (2) conduct a small pilot RCT (randomized controlled trial) of FED-F (n=30) as compared to TAU (n=30; Phase II), and (3) examine if FED-F targets approach/avoidance behaviors and test if this mechanism is associated with clinical outcomes (Phase II).

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa
• Anorexia Nervosa in Remission
• Eating Disorders
• Feeding and Eating Disorders

• NCT number: NCT05596799
• Study type: Interventional
• Source: University of Louisville
• Contact: Cheri A Levinson, Ph.D.
• Phone: 502-852-7710
• Email: cheri.levinson@louisville.edu
• Status: Recruiting
• Phase: N/A
• Start date: December 8, 2022
• Completion date: February 1, 2025